Activin, part of the TGF-β superfamily ... better, and more affordable medicine. Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from ...

ARO-ALK7 is the first RNAi therapy targeting adipose tissues and is engineered to suppress the activin A receptor type ... discovery and translational medicine chief James Hamilton said ...